136 related articles for article (PubMed ID: 9167946)
1. Origin and progression of thyroid epithelial tumours: cellular and molecular mechanisms.
Wynford-Thomas D
Horm Res; 1997; 47(4-6):145-57. PubMed ID: 9167946
[TBL] [Abstract][Full Text] [Related]
2. [Molecular basis of tumors arising in thyroid follicular cells].
Wynford-Thomas D
Ann Chir; 1999; 53(3):237-43. PubMed ID: 10339867
[TBL] [Abstract][Full Text] [Related]
3. Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.
Bounacer A; Schlumberger M; Wicker R; Du-Villard JA; Caillou B; Sarasin A; Suárez HG
Br J Cancer; 2000 Jan; 82(2):308-14. PubMed ID: 10646882
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathogenesis of thyroid nodules and cancer.
Moretti F; Nanni S; Pontecorvi A
Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):517-39. PubMed ID: 11289733
[TBL] [Abstract][Full Text] [Related]
5. Molecular biology of thyroid neoplasms.
Satta MA; Nanni S; Della Casa S; Pontecorvi A
Rays; 2000; 25(2):151-61. PubMed ID: 11370534
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathogenesis of follicular cell derived thyroid cancers.
Parameswaran R; Brooks S; Sadler GP
Int J Surg; 2010; 8(3):186-93. PubMed ID: 20097316
[TBL] [Abstract][Full Text] [Related]
7. Rearrangements of NTRK1 oncogene in papillary thyroid carcinoma.
Brzeziańska E; Pastuszak-Lewandoska D; Lewiński A
Neuro Endocrinol Lett; 2007 Jun; 28(3):221-9. PubMed ID: 17627253
[TBL] [Abstract][Full Text] [Related]
8. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of epithelial thyroid tumorigenesis.
Suarez HG
C R Acad Sci III; 2000 Jun; 323(6):519-28. PubMed ID: 10923207
[TBL] [Abstract][Full Text] [Related]
10. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)).
Carta C; Moretti S; Passeri L; Barbi F; Avenia N; Cavaliere A; Monacelli M; Macchiarulo A; Santeusanio F; Tartaglia M; Puxeddu E
Clin Endocrinol (Oxf); 2006 Jan; 64(1):105-9. PubMed ID: 16402937
[TBL] [Abstract][Full Text] [Related]
11. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.
Mechler C; Bounacer A; Suarez H; Saint Frison M; Magois C; Aillet G; Gaulier A
Br J Cancer; 2001 Dec; 85(12):1831-7. PubMed ID: 11747322
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
Fagin JA; Matsuo K; Karmakar A; Chen DL; Tang SH; Koeffler HP
J Clin Invest; 1993 Jan; 91(1):179-84. PubMed ID: 8423216
[TBL] [Abstract][Full Text] [Related]
13. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
14. Structure and expression of nuclear oncogenes in multi-stage thyroid tumorigenesis.
Wyllie FS; Lemoine NR; Williams ED; Wynford-Thomas D
Br J Cancer; 1989 Oct; 60(4):561-5. PubMed ID: 2803926
[TBL] [Abstract][Full Text] [Related]
15. In vitro reconstruction of tumour initiation in a human epithelium.
Bond JA; Wyllie FS; Rowson J; Radulescu A; Wynford-Thomas D
Oncogene; 1994 Jan; 9(1):281-90. PubMed ID: 8302590
[TBL] [Abstract][Full Text] [Related]
16. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms and pathogenesis of thyroid cancer in animals and man.
Williams ED
Mutat Res; 1995 Dec; 333(1-2):123-9. PubMed ID: 8538619
[TBL] [Abstract][Full Text] [Related]
18. Role of ras and gsp oncogenes in human epithelial thyroid tumorigenesis.
Du Villard JA; Schlumberger M; Wicker R; Caillou B; Rochefort P; Feunteun J; Monier R; Parmentier C; Suarez HG
J Endocrinol Invest; 1995 Feb; 18(2):124-6. PubMed ID: 7629378
[No Abstract] [Full Text] [Related]
19. Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin.
Motoi N; Sakamoto A; Yamochi T; Horiuchi H; Motoi T; Machinami R
Pathol Res Pract; 2000; 196(1):1-7. PubMed ID: 10674266
[TBL] [Abstract][Full Text] [Related]
20. RET/PTC fusion gene rearrangements in Japanese thyroid carcinomas.
Nibu K; Otsuki N; Nakao K; Sugasawa M; Rothstein JL
Eur Arch Otorhinolaryngol; 2005 May; 262(5):368-73. PubMed ID: 15368067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
